Canakinumab Subcutaneous and Xopenex Pediatric
Determining the interaction of Canakinumab Subcutaneous and Xopenex Pediatric and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: levalbuterol
Brand name: Xopenex, Xopenex Concentrate, Xopenex HFA
Synonyms: Levalbuterol inhalation, Levalbuterol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Xospata
- Canakinumab Subcutaneous-Xoten-C
- Canakinumab Subcutaneous-Xpect-AT
- Canakinumab Subcutaneous-Xpect-PE
- Canakinumab Subcutaneous-Xpovio
- Canakinumab Subcutaneous-Xpovio (100 MG Once Weekly)
- Xopenex Pediatric-Canasa
- Xopenex Pediatric-Canasa Pac rectal
- Xopenex Pediatric-Canasa rectal
- Xopenex Pediatric-Cancidas
- Xopenex Pediatric-Candesartan
- Xopenex Pediatric-Candesartan and Hydrochlorothiazide